114 related articles for article (PubMed ID: 35245633)
1. The effectiveness of synthetic methoxylated isoflavones in delivering to the skin and alleviating psoriasiform lesions via topical absorption.
Tseng CH; Lin CF; Aljuffali IA; Huang JR; Yang SH; Fang JY
Int J Pharm; 2022 Apr; 617():121629. PubMed ID: 35245633
[TBL] [Abstract][Full Text] [Related]
2. A systematic comparison of the effect of topically applied anthraquinone aglycones to relieve psoriasiform lesion: The evaluation of percutaneous absorption and anti-inflammatory potency.
Lin CF; Chuang SY; Huang TH; Nguyen TMH; Wang PW; Alalaiwe A; Fang JY
Biomed Pharmacother; 2022 Jan; 145():112482. PubMed ID: 34915669
[TBL] [Abstract][Full Text] [Related]
3. Percutaneous absorption of resveratrol and its oligomers to relieve psoriasiform lesions: In silico, in vitro and in vivo evaluations.
Cheng CY; Lin YK; Yang SC; Alalaiwe A; Lin CJ; Fang JY; Lin CF
Int J Pharm; 2020 Jul; 585():119507. PubMed ID: 32512223
[TBL] [Abstract][Full Text] [Related]
4. Development of flavanone and its derivatives as topical agents against psoriasis: The prediction of therapeutic efficiency through skin permeation evaluation and cell-based assay.
Alalaiwe A; Lin CF; Hsiao CY; Chen EL; Lin CY; Lien WC; Fang JY
Int J Pharm; 2020 May; 581():119256. PubMed ID: 32220586
[TBL] [Abstract][Full Text] [Related]
5. The Therapeutic Potential and Molecular Mechanism of Isoflavone Extract against Psoriasis.
Li HJ; Wu NL; Lee GA; Hung CF
Sci Rep; 2018 Apr; 8(1):6335. PubMed ID: 29679037
[TBL] [Abstract][Full Text] [Related]
6. The elucidation of structure-activity and structure-permeation relationships for the cutaneous delivery of phytosterols to attenuate psoriasiform inflammation.
Chang ZY; Chen CW; Tsai MJ; Chen CC; Alshetaili A; Hsiao YT; Fang JY
Int Immunopharmacol; 2023 Jun; 119():110202. PubMed ID: 37075671
[TBL] [Abstract][Full Text] [Related]
7. Anoctamin1 Induces Hyperproliferation of HaCaT Keratinocytes and Triggers Imiquimod-Induced Psoriasis-Like Skin Injury in Mice.
Choi MR; Kim HD; Cho S; Jeon SH; Kim DH; Wee J; Yang YD
Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281197
[TBL] [Abstract][Full Text] [Related]
8. Daphnetin inhibits proliferation and inflammatory response in human HaCaT keratinocytes and ameliorates imiquimod-induced psoriasis-like skin lesion in mice.
Gao J; Chen F; Fang H; Mi J; Qi Q; Yang M
Biol Res; 2020 Oct; 53(1):48. PubMed ID: 33081840
[TBL] [Abstract][Full Text] [Related]
9. Capsaicin attenuates imiquimod-induced epidermal hyperplasia and cutaneous inflammation in a murine model of psoriasis.
Chan TC; Lee MS; Huang WC; Chang WY; Krueger JG; Tsai TF
Biomed Pharmacother; 2021 Sep; 141():111950. PubMed ID: 34328106
[TBL] [Abstract][Full Text] [Related]
10. Dang-Gui-Liu-Huang Tang a traditional herbal formula, ameliorates imiquimod-induced psoriasis-like skin inflammation in mice by inhibiting IL-22 production.
Nguyen LTH; Ahn SH; Nguyen UT; Yang IJ
Phytomedicine; 2018 Aug; 47():48-57. PubMed ID: 30166108
[TBL] [Abstract][Full Text] [Related]
11. Glycerol Improves Skin Lesion Development in the Imiquimod Mouse Model of Psoriasis: Experimental Confirmation of Anecdotal Reports from Patients with Psoriasis.
Choudhary V; Kaddour-Djebbar I; Custer VE; Uaratanawong R; Chen X; Cohen E; Yang R; Ajebo E; Hossack S; Bollag WB
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445455
[TBL] [Abstract][Full Text] [Related]
12. Dietary olive oil intake aggravates psoriatic skin inflammation in mice via Nrf2 activation and polyunsaturated fatty acid imbalance.
Donato-Trancoso A; Correa Atella G; Romana-Souza B
Int Immunopharmacol; 2022 Jul; 108():108851. PubMed ID: 35588658
[TBL] [Abstract][Full Text] [Related]
13. Polydopamine/IR820 nanoparticles as topical phototheranostics for inhibiting psoriasiform lesions through dual photothermal and photodynamic treatments.
Nirmal GR; Lin ZC; Lin CH; Sung CT; Liao CC; Fang JY
Biomater Sci; 2022 Oct; 10(21):6172-6189. PubMed ID: 36073349
[TBL] [Abstract][Full Text] [Related]
14. Losartan ointment attenuates imiquimod-induced psoriasis-like inflammation.
Shokrian Zeini M; Haddadi NS; Shayan M; Shokrian Zeini M; Kazemi K; Solaimanian S; Abdollahifar MA; Hedayatyanfard K; Dehpour AR
Int Immunopharmacol; 2021 Nov; 100():108160. PubMed ID: 34583123
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of IL-17-committed T cells in a murine psoriasis model by a vitamin D analogue.
Kusuba N; Kitoh A; Dainichi T; Honda T; Otsuka A; Egawa G; Nakajima S; Miyachi Y; Kabashima K
J Allergy Clin Immunol; 2018 Mar; 141(3):972-981.e10. PubMed ID: 28870465
[TBL] [Abstract][Full Text] [Related]
16. Facile skin targeting of a thalidomide analog containing benzyl chloride moiety alleviates experimental psoriasis via the suppression of MAPK/NF-κB/AP-1 phosphorylation in keratinocytes.
Tang KW; Lin ZC; Wang PW; Alalaiwe A; Tseng CH; Fang JY
J Dermatol Sci; 2020 Aug; 99(2):90-99. PubMed ID: 32622642
[TBL] [Abstract][Full Text] [Related]
17. Effect of γ-secretase inhibitor on Th17 cell differentiation and function of mouse psoriasis-like skin inflammation.
Ma L; Xue H; Qi R; Wang Y; Yuan L
J Transl Med; 2018 Mar; 16(1):59. PubMed ID: 29523162
[TBL] [Abstract][Full Text] [Related]
18. Protectin D1 reduces imiquimod-induced psoriasiform skin inflammation.
Park KD; Kim N; Kang J; Dhakal H; Kim JY; Jang YH; Lee WJ; Lee SJ; Kim SH
Int Immunopharmacol; 2021 Sep; 98():107883. PubMed ID: 34153674
[TBL] [Abstract][Full Text] [Related]
19. The active compounds derived from Psoralea corylifolia for photochemotherapy against psoriasis-like lesions: The relationship between structure and percutaneous absorption.
Alalaiwe A; Hung CF; Leu YL; Tahara K; Chen HH; Hu KY; Fang JY
Eur J Pharm Sci; 2018 Nov; 124():114-126. PubMed ID: 30153523
[TBL] [Abstract][Full Text] [Related]
20. Cimifugin ameliorates imiquimod-induced psoriasis by inhibiting oxidative stress and inflammation via NF-κB/MAPK pathway.
Liu A; Zhao W; Zhang B; Tu Y; Wang Q; Li J
Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32515468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
